Navigation Links
Major State Grant Accelerates Research and Development of Novel Cancer Therapy
Date:9/5/2008

nt that generates reactive oxygen species selectively targets and kills cancer cells, but not normal cells. Based on these findings, they formulated a topical skin preparation for CHS which is currently being tested for treatment of AK. Ongoing research of this therapy is also underway in Weissbach's laboratory to determine the mechanisms of action of the drug combination, and to design and synthesize more active derivatives as potential anti-cancer agents.

"Innovation is one of the single-most important factors in determining America's future success and our ability to lead the way in discoveries that save lives and improve the quality of life," said Stephen Chakoff, president of CHS. "The SURECAG funds will enable CHS to continue our efforts to develop the topical skin drug product and hopefully position our company for a private placement and equity fund investment to bring this drug product utilizing the FAU-licensed intellectual property through FDA trials and into the marketplace."

FAU will benefit through the licensing fees as CHS achieves its milestones and through royalties from the sale of products based on FAU's intellectual property. FAU will maintain a stake in CHS and will be able to build a world-wide intellectual property portfolio to enhance the programs surrounding this discovery.

"This is an important step forward," said Weissbach. "The SURECAG program will enable both FAU and CHS to move the project forward with the hope of obtaining a new therapy to treat skin and other cancers. Furthermore, CHS is adding to the growing life science sector in Florida, a state that has a high incidence of skin cancer."

Skin cancer is the most prevalent form of cancer in the world. The two most common types of non-melanoma skin cancers are basal cell carcinoma and squamous cell carcinoma (SCC). One in five Americans will develop some form of skin cancer at some point in their lives, and it is estimated that over one million Americans wi
'/>"/>

SOURCE Florida Atlantic University
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aspirin Named 8th World Wonder by Majority of Americans
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
5. ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx
6. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
7. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting
10. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
11. Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014 STAAR Surgical Company (NASDAQ: ... of implantable lenses and delivery systems for the eye ... and conference call with investors to July 31, 2014 ... Company rescheduled the release date and conference call to ... Hideo Watanabe , President of STAAR Japan, who ...
(Date:7/28/2014)... MDXG ), an integrated developer, processor and marketer ... amniotic membrane, announced today its results for the quarter ended ... Revenue exceeds upper end of guidance and increases by ... Quarter-over-quarter revenue grew by 31% , ... and 40% sequentially over Q1 2014 , ...
(Date:7/28/2014)... N.J. , July 28, 2014   ... $520,000 settlement of off-label marketing and fraud claims ... and Vascular Solutions, Inc. ("VSI").  The settlement covers ... medical devices for endovenous laser ablation of varicose ... Magnanini, a firm with a history of representing ...
Breaking Medicine Technology:STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2MiMedx Announces Record Second Quarter Results 2MiMedx Announces Record Second Quarter Results 3MiMedx Announces Record Second Quarter Results 4MiMedx Announces Record Second Quarter Results 5MiMedx Announces Record Second Quarter Results 6MiMedx Announces Record Second Quarter Results 7MiMedx Announces Record Second Quarter Results 8MiMedx Announces Record Second Quarter Results 9MiMedx Announces Record Second Quarter Results 10MiMedx Announces Record Second Quarter Results 11MiMedx Announces Record Second Quarter Results 12MiMedx Announces Record Second Quarter Results 13MiMedx Announces Record Second Quarter Results 14MiMedx Announces Record Second Quarter Results 15MiMedx Announces Record Second Quarter Results 16MiMedx Announces Record Second Quarter Results 17MiMedx Announces Record Second Quarter Results 18Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 2Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 3
... 15, 2011 Reportlinker.com announces that ... available in its catalogue: ... Facial Aesthetics and Medical Laser Devices ... The combined ...
... 2011 /PRNewswire-iReach/ -- URINOZINC® Prostate Formula ... (Photo:   http://photos.prnewswire.com/prnh/20110614/CG20097 ) The original, ... all corporate-owned GNC Live Well stores and at ... has more than 6,000 stores spread over 49 ...
Cached Medicine Technology:Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 2Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 3Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 4Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 5Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 6Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 7Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 8Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 9Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 10Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 11Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 12Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 13Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 14Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 15Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 16Patented URINOZINC® Prostate Formula Now Available at GNC Stores 2Patented URINOZINC® Prostate Formula Now Available at GNC Stores 3
(Date:7/29/2014)... The Multiple System Atrophy Coalition, a growing ... of five new members to its Board of Directors. ... of its executive directors. The MSA Coalition now ... Physician Advisors. These 12 dedicated volunteers are fully ... support, advocacy and research funding for the neurological disorder ...
(Date:7/29/2014)... CA (PRWEB) July 29, 2014 ... 3.1 out of 5. This score reflects a buyer's ... of the large number of suppliers, the product's widespread ... market, says IBISWorld analyst Jordan Weinstein. IBISWorld estimates that ... with a substantial number of supplier options. However, recent ...
(Date:7/29/2014)... Ticketability.com has reduced the cost of Phantom of ... lower prices on the secure website. Customers are invited to ... tickets that are priced lower every day. , Click ... Ticketability.com. , Theatergoers know that attending an entertaining show can ... the Opera tickets for sale that are priced to fit ...
(Date:7/28/2014)... gene controlling red blood cell development have spread from ... according to a new study led by King,s College ... populations to look for the origin of changes in ... into adulthood. Fetal haemoglobin is normally found in fetuses ... who are able to keep making it as adults ...
(Date:7/28/2014)... Anapolis, MD (PRWEB) July 28, 2014 Evolve ... July 16, 2014, offering its members virtual visits and dramatic ... care. , Some estimates state that as many as ... conducted virtually. “Imagine not having to leave your office or ... on your blood pressure or cholesterol,” CEO and Founder Michael ...
Breaking Medicine News(10 mins):Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 4Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 4Health News:Phantom of the Opera Tickets for Sale: Ticketability.com Delights Customers with Phantom of the Opera Theatre Tickets While Seats Last 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 3Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 2Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 3Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 4
... Patients to Provide Direct Feedback ... and Award Nurses for Compassionate Care, ... of Interactive Patient Care (IPC) solutions, today announced that,it ... recognize the,exceptional work of nurses through the DAISY Award ...
... 2, 2008) - In an article featured on the ... Ferrari, Ph.D., of The University of Texas Health Science ... new multistage delivery system (MDS) for imaging and therapeutic ... making injectable drugs more effective. The study is included ...
... nano-sensor for better detection of Mad Cow Disease agent, ... food safety, researchers in New York are reporting development ... of the deadly prion proteins that cause Mad Cow ... detects binding of prion proteins by detecting frequency changes ...
... develops tool to test for kids who may have this ... working memory, rather than low intelligence, could be the reason ... study. , Working memory is the ability to retain and ... aid of pen and paper or a calculator. Students need ...
... Inc.,(Nasdaq: IWOV ), a global leader in ... a joint session with Blue Cross Blue Shield,of ... Conference,on March 6th at 12 noon at the ... http://www.newscom.com/cgi-bin/prnh/20071205/INTWOVLOGO ), The session, entitled "Putting Content ...
... (NYSE: T ),announced today the deployment of ... and mobile broadband access for the customers at,Thomas ... committed to excellence in patient care," said Stephen,Tranquillo, ... at every level is vital to the patient ...
Cached Medicine News:Health News:GetWellNetwork Partners with DAISY Foundation to Recognize Extraordinary Nurses 2Health News:GetWellNetwork Partners with DAISY Foundation to Recognize Extraordinary Nurses 3Health News:GetWellNetwork Partners with DAISY Foundation to Recognize Extraordinary Nurses 4Health News:Nanomedicine system engineered to enhance therapeutic effects of injectable drugs 2Health News:Nanomedicine system engineered to enhance therapeutic effects of injectable drugs 3Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 2Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 3Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 4Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 5Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 6Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 7Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 8Health News:American Chemical Society's weekly PressPac -- Feb. 27, 2008 9Health News:Poor Working Memory Tied to Low School Scores 2Health News:Blue Cross Blue Shield of Massachusetts and Interwoven to Present at 2008 AIIM International Exposition and Conference 2Health News:AT&T Provides In-Building Wireless Services to Thomas Jefferson University and Hospital 2Health News:AT&T Provides In-Building Wireless Services to Thomas Jefferson University and Hospital 3
... Eye is based on a powerful, easy-to-use ... serve the specific treatment and business requirements ... office.,Designed to provide patient care assistance as ... is accurate, AllMeds for Eye's simple "point ...
... an Electronic Medical Office (EMO) for the ... of your practice. In addition to retrieving ... electronically integrates the patient office flow including ... and billing information. ChartLogic also gives you ...
... from Laboratory Data Systems, Inc is the first ... to the specific needs of POC (managed from ... Care or Lab). The design of AegisPOC ensures ... to manage their testing programs in the manner ...
...
Medicine Products: